Cubist Systematic Strategies, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$116,000
+107.1%
39,187
+212.8%
0.00%0.0%
Q4 2021$56,000
-77.5%
12,526
-65.7%
0.00%
-66.7%
Q2 2021$249,000
+18.6%
36,486
+22.7%
0.00%0.0%
Q1 2021$210,000
-13.2%
29,739
-23.0%
0.00%0.0%
Q4 2020$242,000
-18.5%
38,601
-29.7%
0.00%
-25.0%
Q3 2020$297,000
+113.7%
54,947
+111.9%
0.00%
-20.0%
Q1 2019$139,000
+13.9%
25,927
+8.6%
0.01%
-16.7%
Q4 2018$122,000
-17.0%
23,868
+111.7%
0.01%
-33.3%
Q1 2018$147,000
+1236.4%
11,274
+1271.5%
0.01%
+800.0%
Q3 2016$11,000
-82.8%
822
-82.3%
0.00%
-75.0%
Q2 2016$64,0004,6330.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders